Grown Rogue International (GRUSF) Free Cash Flow (2013 - 2026)
Grown Rogue International (GRUSF) posted quarterly Free Cash Flow of $17110.0 for Q1 2026, up 102.57% year-over-year from $8446.6 in Q1 2025, and up 100.0% quarter-over-quarter from -$1287.2 billion in Q4 2025.
Grown Rogue International (GRUSF) Free Cash Flow (2013 - 2026) Analysis & Trends
Grown Rogue International's Free Cash Flow history runs 14 years deep, the most recent figure standing at $17110.0 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 102.57% year-over-year to $17110.0; the TTM figure through Mar 2026 stood at -$230.7 billion (down 6532417.43% YoY), while the FY2025 annual figure was -$1.1 million, down 121.36% from the prior year.
- Free Cash Flow for Q1 2026 stood at $17110.0, up from -$1287.2 billion in the prior quarter.
- The five-year high for Free Cash Flow was $1056.5 billion in Q3 2025, with the low at -$1287.2 billion in Q4 2025.
- The 5-year median for Free Cash Flow is $995729.7 (2024), against an average of -$17.7 billion.
- Peak annual rise in Free Cash Flow reached 86248785.29% in 2025, while the deepest fall reached 85066906.27% in 2025.
- Grown Rogue International's Free Cash Flow stood at $634698.1 in 2022, then surged by 465.13% to $3.6 million in 2023, then sank by 57.81% to $1.5 million in 2024, then sank by 85066906.27% to -$1287.2 billion in 2025, then jumped by 100.0% to $17110.0 in 2026.
- Business Quant data shows GRUSF's Free Cash Flow at $17110.0 in Q1 2026, -$1287.2 billion in Q4 2025, and $1056.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn | -1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.27 Mn |
| Jun 30, 2026 | -1.27 Mn |
| Mar 31, 2026 | 17,110.00 |
| Mar 31, 2026 | 17,110.00 |
| Dec 31, 2025 | -1,287.22 Bn |
| Dec 31, 2025 | -1,287.22 Bn |
| Sep 30, 2025 | 1,056.50 Bn |
| Sep 30, 2025 | 1,056.50 Bn |
| Jun 30, 2025 | 503,483.96 |
| Jun 30, 2025 | 503,483.96 |
| Mar 31, 2025 | -666,732.33 |
| Mar 31, 2025 | -666,732.33 |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 995,729.65 |
| Mar 31, 2024 | 995,729.65 |